EIF2A and Alzheimer disease: The delayed activation of the UPR over the course of AD within the neocortical regions is further supported by similar findings within the frontal cortex, in which p-PERK was selectively elevated in Braak stage 6 cases, in the absence of enhanced p-eIF2α levels [64].